Peptide Injection Guides

Common Injection Mistakes

Even experienced researchers make injection errors that can reduce effectiveness, increase discomfort, or create safety risks. This guide catalogs the most common mistakes and provides clear corrective actions for each.

Beginner Guides

First-Time Injection Guide

Your first self-injection can feel intimidating, and that is completely normal. Needle anxiety is common even among healthcare professionals during training. This guide walks you through everything from mental preparation to your first injection, with practical tips for managing anxiety and building confidence.

Abdominal Injection Site Guide

The abdomen is the most popular subcutaneous injection site for peptide research. It offers a large surface area, consistent subcutaneous fat depth, reliable absorption rates, and easy access for self-administration. This guide covers precise site selection, technique refinements, and rotation strategies.

Upper Arm Injection Site Guide

The upper arm (deltoid region) serves as a third injection site option, commonly used for both subcutaneous and intramuscular administration. While less accessible for self-injection than the abdomen or thigh, the back of the upper arm provides adequate subcutaneous tissue for peptide delivery.

Gluteal Injection Site Guide

The gluteal region provides the largest muscle mass for intramuscular injections, making it suitable for larger volume injections (up to 5mL). The ventrogluteal site is strongly preferred over the dorsogluteal due to a lower risk of nerve or vessel injury. This guide covers both sites with emphasis on the safer ventrogluteal approach.

Injection Site Reactions

Injection site reactions (ISRs) are the most common side effects of subcutaneous and intramuscular injections. Most are mild, self-limiting, and do not require intervention. However, distinguishing normal reactions from signs of infection or allergic response is critical for safety. This guide covers the spectrum of reactions, their causes, and when to seek medical attention.

Thigh Injection Site Guide

The thigh is an excellent alternative injection site offering easy self-access and suitability for both subcutaneous and intramuscular injections. The outer middle third of the thigh (vastus lateralis region) provides consistent fat depth for SubQ and a large muscle mass for IM administration.

Injection Techniques

Intramuscular Injection Technique

Intramuscular (IM) injections deliver substances directly into muscle tissue, providing faster absorption than subcutaneous injections due to the rich blood supply in muscle. While less common for peptide research, certain compounds and larger volumes may require IM administration.

Equipment

Needle & Syringe Selection Guide

Selecting the appropriate needle and syringe is fundamental to safe and effective peptide administration. The right combination depends on the injection route (SubQ vs IM), volume to be injected, solution viscosity, and injection site. This guide breaks down the key variables and recommends the best options for common peptide research scenarios.

Peptide Storage & Handling Guide

Proper storage is critical for maintaining peptide potency and safety. Peptides are proteins that degrade when exposed to heat, light, moisture, and bacterial contamination. Understanding storage requirements at each stage—unreconstituted, reconstituted, and during transport—ensures your research materials remain viable throughout their usable life.

Post-Injection Care

What you do after an injection matters for both safety and comfort. Proper post-injection care includes safe needle disposal, site monitoring, and knowing what is normal versus concerning. This guide covers everything from the moment you withdraw the needle to follow-up in the days after.

Injection Techniques

Peptide Reconstitution Guide

Most research peptides arrive as lyophilized (freeze-dried) powder that must be reconstituted with bacteriostatic water before use. Proper reconstitution technique preserves peptide integrity, ensures accurate dosing, and maximizes vial shelf life. This guide walks through every step from vial inspection to final storage.

Injection Site Rotation Schedule

Systematic injection site rotation is essential for maintaining tissue health and consistent absorption. Repeated injections at the same location can cause lipodystrophy (abnormal fat distribution), scar tissue buildup, and variable absorption rates. A structured rotation schedule prevents these complications and extends the usability of your injection sites.

Sterile Injection Technique

Maintaining sterility throughout the injection process is the most important safety practice in peptide research. A single contamination event can introduce bacteria into subcutaneous tissue, potentially causing abscess, cellulitis, or systemic infection. This guide establishes the aseptic practices that minimize contamination risk at every step.

Injection Techniques

Subcutaneous Injection Technique

Subcutaneous (SubQ) injections deliver substances into the fatty tissue layer between the skin and muscle. This is the most common administration route for peptide research due to its simplicity, slower absorption profile, and minimal discomfort. Proper technique ensures consistent delivery and reduces the risk of complications.

Peptide-Specific Injection Guides

How to Administer 5-Amino-1MQ

5-Amino-1MQ is a small molecule NNMT inhibitor taken orally—it is NOT a peptide and is NOT injected. It is available as a capsule or tablet for oral administration, targeting nicotinamide N-methyltransferase to support metabolic function.

Where to Inject AOD-9604

AOD-9604 is a modified fragment of human growth hormone (HGH fragment 177-191) studied for fat metabolism. Some protocols suggest injecting near adipose tissue depots for potentially enhanced local lipolytic effects.

Where to Inject BPC-157

BPC-157 is one of the few peptides where injection site location may significantly influence outcomes. Research suggests that injecting near the target tissue (local administration) may provide enhanced local effects compared to distant injection, though systemic effects are also observed regardless of site.

Where to Inject CagriSema

CagriSema is a combination of cagrilintide (amylin analog) and semaglutide (GLP-1 agonist) co-formulated for once-weekly subcutaneous injection. It follows standard SubQ injection guidelines.

Where to Inject CJC-1295

CJC-1295 is a GHRH analog available in two forms: with DAC (long half-life, 1-2x weekly) and without DAC/Mod GRF 1-29 (short half-life, 1-3x daily). Injection technique is standard SubQ for both versions.

Where to Inject Epitalon

Epitalon (Epithalon) is a synthetic tetrapeptide studied for telomerase activation and anti-aging. It is administered subcutaneously with standard technique.

Where to Inject FOXO4-DRI

FOXO4-DRI is a senolytic peptide designed to selectively clear senescent cells. It is administered subcutaneously with standard technique, typically in short treatment cycles.

Where to Inject GHK-Cu

GHK-Cu (copper peptide) is used in both topical and injectable forms. When administered subcutaneously, it can be injected near the target area for localized effects or in standard sites for systemic benefits.

Where to Inject Ipamorelin

Ipamorelin is a selective growth hormone secretagogue typically administered 1-3 times daily via subcutaneous injection. Timing relative to meals is critical—ipamorelin must be taken fasted for optimal GH release.

Where to Inject Melanotan II

Melanotan II is a synthetic melanocortin peptide administered subcutaneously. It is typically injected in the abdomen using standard SubQ technique with low-volume doses.

Where to Inject MOTS-c

MOTS-c is a mitochondrial-derived peptide studied for metabolic regulation and exercise mimetic effects. It is administered subcutaneously with standard technique.

How to Administer Orforglipron

Orforglipron is an investigational oral GLP-1 receptor agonist—it is taken by mouth, NOT injected. It represents a new class of non-peptide, small-molecule GLP-1 agonists designed to replicate the effects of injectable semaglutide in a convenient daily pill.

Where to Inject Retatrutide

Retatrutide is a triple agonist (GIP/GLP-1/glucagon) in clinical trials for weight management. As a subcutaneous peptide, it follows standard injection site guidelines similar to other incretin-based therapies.

How to Administer Selank

Selank is a synthetic peptide derived from tuftsin, administered intranasally. Like Semax, it is NOT injected. The intranasal route provides direct access to the central nervous system for its anxiolytic and nootropic effects.

Where to Inject Semaglutide

Semaglutide (Ozempic/Wegovy) is a once-weekly GLP-1 receptor agonist with well-established injection guidelines from FDA-approved labeling. The three approved injection sites—abdomen, thigh, and upper arm—all provide equivalent bioavailability.

How to Administer Semax

Semax is a synthetic peptide analog of ACTH administered intranasally—it is NOT injected. The nasal spray route provides rapid absorption through the nasal mucosa with direct access to the central nervous system, making it the preferred and standard route for this nootropic peptide.

Where to Inject TB-500

TB-500 (Thymosin Beta-4 fragment) acts systemically through its role in actin regulation and cell migration. Unlike BPC-157, injection site location has minimal impact on efficacy because TB-500 distributes throughout the body regardless of where it is administered.

Where to Inject Tesamorelin

Tesamorelin (Egrifta) is an FDA-approved GHRH analog for HIV-associated lipodystrophy. It is administered as a once-daily subcutaneous abdominal injection.

How to Administer Tesofensine

Tesofensine is an oral triple monoamine reuptake inhibitor studied for weight management—it is taken by mouth as a tablet, NOT injected. It was originally developed for neurological conditions before its weight loss effects were discovered.

Where to Inject Tirzepatide

Tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 receptor agonist administered once weekly via subcutaneous injection. Injection guidelines parallel semaglutide with the same three approved sites.